Presentation | July 11, 2024

Mycenax BsAb Services

Source: Mycenax
GettyImages-1302640919-antibody

Mycenax specializes in CDMO services for bispecific and multi-specific antibodies (BsAbs/MsAbs). We offer a comprehensive suite of services encompassing feasibility studies, cell line development, process development, and culminating in Good Manufacturing Practice (GMP) production. Our extensive experience encompasses a broad spectrum of BsAb and MsAb formats, including asymmetric heterodimers, symmetric fragment-Fc homodimers, and symmetric appended IgG homodimers. Mycenax prioritizes client-centricity, tailoring our services to accommodate specific needs while ensuring strict adherence to the rigorous quality standards mandated by regulatory authorities in the United States, Europe, and Japan.

access the Presentation!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma